Diagnostic companies delivered strong Q2 earnings driven by volume growth and deeper penetration, says SBI Cap Securities’ Sunny Agrawal. Midcap IT continues to outperform on rupee tailwinds and easing global uncertainty, though valuations remain high. Agrawal expects the RBI to pause rate cuts and advises caution on richly valued Kaynes Technology amid governance concerns.